NORTHSTAR HLTHCARE
GenericsNORTHSTAR HLTHCARE is a generic drug manufacturer focused on Neurology, Cardiovascular.
NORTHSTAR HLTHCARE's Key Drugs
NORTHSTAR HLTHCARE's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
NORTHSTAR HLTHCARE's Recent FDA Approvals
New NDA/BLA approvals for NORTHSTAR HLTHCARE over the last two years — novel drugs only, excluding generics and label supplements.
NORTHSTAR HLTHCARE's Therapeutic Areas
NORTHSTAR HLTHCARE's approved drugs and pipeline span 2 therapeutic areas, led by Neurology and Cardiovascular. Weighted by commercial stage — approved drugs count most, then late-stage trials.
NORTHSTAR HLTHCARE's Top Competitors
NORTHSTAR HLTHCARE's closest competitors by therapeutic-area and drug-target overlap include GE HEALTHCARE, Novo Nordisk, and LEDERLE. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
NORTHSTAR HLTHCARE Pipeline Snapshot
Active clinical trials for NORTHSTAR HLTHCARE across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Neurology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2007-09-10
- Latest
- 2024-05-31
- Applications
- 12